comparemela.com

Latest Breaking News On - Melt pharmaceuticals - Page 5 : comparemela.com

Harrow Health (NASDAQ:HROW) Trading 6.5% Higher

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report)’s share price was up 6.5% during trading on Monday . The stock traded as high as $15.89 and last traded at $15.80. Approximately 191,766 shares were traded during trading, a decline of 58% from the average daily volume of 455,751 shares. The stock had previously closed at […]

Markl-baum
Martina-makary
Wasatch-advisors-inc
Nasdaq
Harrow-health
Surface-ophthalmics-inc
Harrow-health-company-profile
Hedge-funds-weigh-in-on-harrow-health
Blackrock-inc
Harrow-health-inc
Envestnet-asset-management-inc

Mark L. Baum Purchases 5,800 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stock

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 5,800 shares of the company’s stock in a transaction that occurred on Monday, August 14th. The shares were acquired at an average price of $17.05 per share, with a total value of $98,890.00. Following the completion of the transaction, the chief executive […]

Markl-baum
News-ratings-for-harrow-health-daily
Harrow-health-inc
Surface-ophthalmics-inc
Harrow-health
Securities-exchange-commission
Pharmaceuticals-inc
Capital-management
Nasdaq
Eton-pharmaceuticals-inc
Blackrock-inc

Harrow Health, Inc. (NASDAQ:HROW) Director Buys $338,400.00 in Stock

Harrow Health, Inc. (NASDAQ:HROW) Director Buys $338,400.00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Martina-makary
Envestnet-asset-management-inc
Pharmaceuticals-inc
Harrow-health-trading-down
Prelude-capital-management
Blackrock-inc
Wasatch-advisors-inc
News-ratings-for-harrow-health-daily
Harrow-health
Eton-pharmaceuticals-inc
Harrow-health-company-profile

Harrow Health (NASDAQ:HROW) Shares Gap Up on Insider Buying Activity

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report)’s stock price gapped up before the market opened on Tuesday following insider buying activity. The stock had previously closed at $17.28, but opened at $17.64. Harrow Health shares last traded at $17.73, with a volume of 81,425 shares trading hands. Specifically, CEO Mark L. Baum acquired 5,800 […]

Markl-baum
Martina-makary
News-ratings-for-harrow-health-daily
Clarivest-asset-management
B-riley-financial-inc
Silver-oak-securities-incorporated
Harrow-health
Securities-exchange-commission
Eton-pharmaceuticals-inc
Harrow-health-price-performance
Institutional-investors-weigh-in-on-harrow-health

Harrow Health (NASDAQ:HROW) Given New $34.40 Price Target at LADENBURG THALM/SH SH

Harrow Health (NASDAQ:HROW – Free Report) had its price objective upped by LADENBURG THALM/SH SH from $33.70 to $34.40 in a report published on Thursday morning, FlyOnTheWall reports. HROW has been the subject of a number of other research reports. B. Riley upped their price target on Harrow Health from $42.00 to $45.00 and gave […]

Blackrock-inc
Surface-ophthalmics-inc
Harrow-health
News-ratings-for-harrow-health-daily
Harrow-health-stock-performance
Harrow-health-inc
Eton-pharmaceuticals-inc
Wasatch-advisors-inc
Pharmaceuticals-inc
Prelude-capital-management
Hedge-funds-weigh-in-on-harrow-health

vimarsana © 2020. All Rights Reserved.